Defunct Company
Total Trials
12
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,106
NCT00822978
Phase 1 Study for Safety of ACHN-490
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 31, 2009
Completion: Oct 31, 2009
NCT01034774
Phase 1 Study to Determine Safety, Blood PK and Lung Penetration
Start: Jan 31, 2010
Completion: Jul 31, 2010
NCT01096849
A Study of Plazomicin Compared With Levofloxacin for the Treatment of Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP)
Phase: Phase 2
Start: Jul 13, 2010
Completion: Apr 3, 2012
NCT01462136
PK Study of ACHN-490 Injection in Renally Impaired Subjects
Start: Sep 30, 2011
Completion: Not specified
NCT01514929
A Study to Evaluate the Effect of IV ACHN-490 Injection on the QT/QTc Interval in Healthy Volunteers
Start: Oct 31, 2011
Completion: Mar 31, 2012
NCT01597947
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 in Healthy Volunteers
Start: May 31, 2012
Completion: Dec 31, 2012
NCT01870245
A Multiple Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 in Healthy Volunteers
Start: May 31, 2013
NCT01970371
A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)
Phase: Phase 3
Start: Sep 16, 2014
Completion: Sep 15, 2016
NCT02486627
A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP)
Start: Jan 11, 2016
Completion: Sep 22, 2016
NCT03163550
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interaction Potential of ACHN-383 and ACHN-789
Start: May 17, 2017
Completion: Oct 15, 2017
NCT03177278
A Study to Assess the Metabolism, Excretion, and Mass Balance of Radio-Labeled Plazomicin
Start: Jun 16, 2017
Completion: Jul 10, 2017
NCT03270553
A Study to Assess the Effect of Plazomicin on the Pharmacokinetics of Metformin
Start: Aug 31, 2017
Completion: Oct 7, 2017